| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | GABA receptor binding | 7.24e-05 | 20 | 82 | 3 | GO:0050811 | |
| Domain | PH_12 | 2.76e-04 | 6 | 81 | 2 | PF16457 | |
| Domain | - | 9.51e-04 | 261 | 81 | 6 | 1.10.238.10 | |
| Domain | EF-hand-dom_pair | 1.55e-03 | 287 | 81 | 6 | IPR011992 | |
| Domain | PLipase_C_Pinositol-sp_Y | 1.88e-03 | 15 | 81 | 2 | IPR001711 | |
| Domain | EF-hand_like | 1.88e-03 | 15 | 81 | 2 | PF09279 | |
| Domain | Myosin_N | 1.88e-03 | 15 | 81 | 2 | PF02736 | |
| Domain | PIPLC_Y_DOMAIN | 1.88e-03 | 15 | 81 | 2 | PS50008 | |
| Domain | Myosin_N | 1.88e-03 | 15 | 81 | 2 | IPR004009 | |
| Domain | PI-PLC_fam | 1.88e-03 | 15 | 81 | 2 | IPR001192 | |
| Domain | PLC_EF-hand-like | 1.88e-03 | 15 | 81 | 2 | IPR015359 | |
| Domain | PI-PLC-Y | 1.88e-03 | 15 | 81 | 2 | PF00387 | |
| Domain | PLCYc | 1.88e-03 | 15 | 81 | 2 | SM00149 | |
| Domain | Actin_CS | 2.14e-03 | 16 | 81 | 2 | IPR004001 | |
| Domain | ACTINS_2 | 2.42e-03 | 17 | 81 | 2 | PS00432 | |
| Domain | Myosin_tail_1 | 2.72e-03 | 18 | 81 | 2 | PF01576 | |
| Domain | Myosin_tail | 2.72e-03 | 18 | 81 | 2 | IPR002928 | |
| Domain | PI-PLC-X | 2.72e-03 | 18 | 81 | 2 | PF00388 | |
| Domain | Actin/actin-like_CS | 2.72e-03 | 18 | 81 | 2 | IPR020902 | |
| Domain | PLCXc | 2.72e-03 | 18 | 81 | 2 | SM00148 | |
| Domain | PIPLC_X_DOMAIN | 3.03e-03 | 19 | 81 | 2 | PS50007 | |
| Domain | PLipase_C_PInositol-sp_X_dom | 3.03e-03 | 19 | 81 | 2 | IPR000909 | |
| Domain | Myosin-like_IQ_dom | 3.03e-03 | 19 | 81 | 2 | IPR027401 | |
| Domain | - | 3.03e-03 | 19 | 81 | 2 | 4.10.270.10 | |
| Domain | ACTINS_ACT_LIKE | 3.03e-03 | 19 | 81 | 2 | PS01132 | |
| Domain | Actinin_actin-bd_CS | 4.43e-03 | 23 | 81 | 2 | IPR001589 | |
| Domain | Spectrin | 4.43e-03 | 23 | 81 | 2 | PF00435 | |
| Domain | ACTININ_2 | 4.43e-03 | 23 | 81 | 2 | PS00020 | |
| Domain | ACTININ_1 | 4.43e-03 | 23 | 81 | 2 | PS00019 | |
| Domain | ANK | 4.71e-03 | 251 | 81 | 5 | SM00248 | |
| Domain | ANK_REPEAT | 4.87e-03 | 253 | 81 | 5 | PS50088 | |
| Domain | ANK_REP_REGION | 4.95e-03 | 254 | 81 | 5 | PS50297 | |
| Domain | EFh | 4.95e-03 | 158 | 81 | 4 | SM00054 | |
| Domain | - | 5.22e-03 | 25 | 81 | 2 | 3.20.20.190 | |
| Domain | PLC-like_Pdiesterase_TIM-brl | 5.22e-03 | 25 | 81 | 2 | IPR017946 | |
| Domain | IQ | 5.26e-03 | 81 | 81 | 3 | SM00015 | |
| Domain | Ankyrin_rpt | 5.63e-03 | 262 | 81 | 5 | IPR002110 | |
| Domain | Spectrin_repeat | 6.99e-03 | 29 | 81 | 2 | IPR002017 | |
| Domain | IQ_motif_EF-hand-BS | 7.04e-03 | 90 | 81 | 3 | IPR000048 | |
| Domain | IQ | 7.71e-03 | 93 | 81 | 3 | PS50096 | |
| Domain | Actin | 7.96e-03 | 31 | 81 | 2 | IPR004000 | |
| Domain | Actin | 7.96e-03 | 31 | 81 | 2 | PF00022 | |
| Domain | ACTIN | 7.96e-03 | 31 | 81 | 2 | SM00268 | |
| Domain | Spectrin/alpha-actinin | 8.47e-03 | 32 | 81 | 2 | IPR018159 | |
| Domain | PAS | 8.47e-03 | 32 | 81 | 2 | SM00091 | |
| Domain | SPEC | 8.47e-03 | 32 | 81 | 2 | SM00150 | |
| Pubmed | TUBGCP6 AKAP5 ILF3 PSIP1 CENPC MACO1 KTN1 VPS35 OTUB1 PDCD11 MRPL19 MACF1 SLC30A1 OGA TRIM24 PREPL GOLGA3 | 6.82e-08 | 1487 | 83 | 17 | 33957083 | |
| Pubmed | MYH10 RNF168 ZNF484 EXPH5 MACO1 VPS35 OTUB1 PLCL2 MACF1 MGA RYR2 | 1.66e-07 | 591 | 83 | 11 | 15231748 | |
| Pubmed | 7.28e-07 | 8 | 83 | 3 | 12475935 | ||
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | CUL1 KDM3A USP6 MYH10 CTPS2 CELF1 PRIM1 KTN1 VPS35 OTUB1 OGA PREPL ARMC8 | 7.39e-07 | 1005 | 83 | 13 | 19615732 |
| Pubmed | 2.40e-06 | 484 | 83 | 9 | 31995728 | ||
| Pubmed | TIF1γ inhibits lung adenocarcinoma EMT and metastasis by interacting with the TAF15/TBP complex. | 4.64e-06 | 179 | 83 | 6 | 36261009 | |
| Pubmed | Gene dosage affects the cardiac and brain phenotype in nonmuscle myosin II-B-depleted mice. | 5.63e-06 | 2 | 83 | 2 | 10712438 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 34859819 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 31589911 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 17301177 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 38734775 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 19553601 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 20097266 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 17254016 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 19996098 | ||
| Pubmed | Identification and characterization of a new phospholipase C-like protein, PLC-L(2). | 5.63e-06 | 2 | 83 | 2 | 10581172 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 12126624 | ||
| Pubmed | 1.13e-05 | 209 | 83 | 6 | 36779422 | ||
| Pubmed | 1.24e-05 | 322 | 83 | 7 | 26514267 | ||
| Pubmed | 1.26e-05 | 754 | 83 | 10 | 35906200 | ||
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 17651496 | ||
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 23639135 | ||
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 23399561 | ||
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 24945349 | ||
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 26706316 | ||
| Pubmed | Involvement of PRIP, phospholipase C-related, but catalytically inactive protein, in bone formation. | 1.69e-05 | 3 | 83 | 2 | 21757756 | |
| Pubmed | 1.73e-05 | 339 | 83 | 7 | 30415952 | ||
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | NES MYH7 MYH10 ILF3 ACACA VPS35 OTUB1 MACF1 ACTN4 XRCC4 OGA PREPL | 1.78e-05 | 1149 | 83 | 12 | 35446349 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | CUL1 NES MYH10 ILF3 ACACA CENPC KTN1 VPS35 PDCD11 MACF1 ACTN4 PRR14L MGA | 1.85e-05 | 1353 | 83 | 13 | 29467282 |
| Pubmed | 2.40e-05 | 493 | 83 | 8 | 15368895 | ||
| Pubmed | 2.54e-05 | 497 | 83 | 8 | 23414517 | ||
| Pubmed | 3.37e-05 | 4 | 83 | 2 | 28202948 | ||
| Pubmed | 3.37e-05 | 4 | 83 | 2 | 28341745 | ||
| Pubmed | 3.37e-05 | 4 | 83 | 2 | 10935545 | ||
| Pubmed | 3.37e-05 | 4 | 83 | 2 | 8482409 | ||
| Pubmed | MYH7 MYH10 AKAP5 ILF3 PSIP1 CENPC POTEF KTN1 VPS35 MACF1 ACTN4 POTEI RYR2 | 3.59e-05 | 1442 | 83 | 13 | 35575683 | |
| Pubmed | 4.44e-05 | 538 | 83 | 8 | 28524877 | ||
| Pubmed | Ligand-dependent contribution of RXRbeta to cholesterol homeostasis in Sertoli cells. | 5.60e-05 | 5 | 83 | 2 | 14993927 | |
| Pubmed | 5.60e-05 | 5 | 83 | 2 | 33871354 | ||
| Pubmed | A critical role for DNA end-joining proteins in both lymphogenesis and neurogenesis. | 5.60e-05 | 5 | 83 | 2 | 9875844 | |
| Pubmed | 5.60e-05 | 5 | 83 | 2 | 30123108 | ||
| Pubmed | Non-canonical inhibition of DNA damage-dependent ubiquitination by OTUB1. | 5.60e-05 | 5 | 83 | 2 | 20725033 | |
| Pubmed | Pioneering function of Isl1 in the epigenetic control of cardiomyocyte cell fate. | 7.43e-05 | 34 | 83 | 3 | 31024170 | |
| Pubmed | 7.43e-05 | 34 | 83 | 3 | 20301725 | ||
| Pubmed | CYLD Regulates Centriolar Satellites Proteostasis by Counteracting the E3 Ligase MIB1. | 7.75e-05 | 182 | 83 | 5 | 31067453 | |
| Pubmed | 8.39e-05 | 6 | 83 | 2 | 20412381 | ||
| Pubmed | Activation of ATP-binding cassette transporter A1 transcription by chromatin remodeling complex. | 8.39e-05 | 6 | 83 | 2 | 15774904 | |
| Pubmed | 8.39e-05 | 6 | 83 | 2 | 9259327 | ||
| Pubmed | 9.28e-05 | 305 | 83 | 6 | 33194618 | ||
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | 9.50e-05 | 444 | 83 | 7 | 34795231 | |
| Pubmed | 9.89e-05 | 963 | 83 | 10 | 28671696 | ||
| Pubmed | 1.17e-04 | 7 | 83 | 2 | 15276201 | ||
| Pubmed | 1.17e-04 | 7 | 83 | 2 | 21126233 | ||
| Pubmed | 1.17e-04 | 7 | 83 | 2 | 16291214 | ||
| Pubmed | 1.17e-04 | 7 | 83 | 2 | 16754670 | ||
| Pubmed | 1.26e-04 | 202 | 83 | 5 | 24639526 | ||
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | 1.32e-04 | 807 | 83 | 9 | 30575818 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | CUL1 MYH10 ILF3 ACACA PSIP1 PRIM1 KTN1 VPS35 OTUB1 PDCD11 ACTN4 ARMC8 | 1.40e-04 | 1425 | 83 | 12 | 30948266 |
| Pubmed | 1.45e-04 | 638 | 83 | 8 | 31182584 | ||
| Pubmed | 1.51e-04 | 1014 | 83 | 10 | 32416067 | ||
| Pubmed | EVI5 CUL1 MYOF MYH10 PSIP1 MACO1 KTN1 VPS35 OTUB1 TMOD1 PDCD11 ARMC8 | 1.55e-04 | 1440 | 83 | 12 | 30833792 | |
| Pubmed | 1.56e-04 | 8 | 83 | 2 | 24293640 | ||
| Pubmed | 1.56e-04 | 8 | 83 | 2 | 9774463 | ||
| Pubmed | Phospholipase C-related but catalytically inactive proteins regulate ovarian follicle development. | 1.56e-04 | 8 | 83 | 2 | 28360101 | |
| Pubmed | 1.66e-04 | 486 | 83 | 7 | 20936779 | ||
| Pubmed | 1.67e-04 | 340 | 83 | 6 | 24332808 | ||
| Pubmed | 1.76e-04 | 116 | 83 | 4 | 21282530 | ||
| Pubmed | 2.00e-04 | 9 | 83 | 2 | 26487682 | ||
| Pubmed | MACF1 regulates the migration of pyramidal neurons via microtubule dynamics and GSK-3 signaling. | 2.00e-04 | 9 | 83 | 2 | 25224226 | |
| Pubmed | 2.00e-04 | 9 | 83 | 2 | 16364570 | ||
| Pubmed | 2.00e-04 | 9 | 83 | 2 | 32576198 | ||
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | 2.07e-04 | 857 | 83 | 9 | 25609649 | |
| Pubmed | 2.28e-04 | 124 | 83 | 4 | 35516420 | ||
| Pubmed | 2.45e-04 | 233 | 83 | 5 | 37704626 | ||
| Pubmed | Comparative mapping in the beige-satin region of mouse chromosome 13. | 2.50e-04 | 10 | 83 | 2 | 9027500 | |
| Pubmed | Natural helix 9 mutants of PPARγ differently affect its transcriptional activity. | 2.50e-04 | 10 | 83 | 2 | 30595551 | |
| Pubmed | Tropomodulin isoforms regulate thin filament pointed-end capping and skeletal muscle physiology. | 2.50e-04 | 10 | 83 | 2 | 20368620 | |
| Pubmed | 2.50e-04 | 10 | 83 | 2 | 16716197 | ||
| Pubmed | 2.50e-04 | 234 | 83 | 5 | 36243803 | ||
| Pubmed | Expanding the Interactome of TES by Exploiting TES Modules with Different Subcellular Localizations. | 2.55e-04 | 235 | 83 | 5 | 28378594 | |
| Pubmed | 2.95e-04 | 1103 | 83 | 10 | 34189442 | ||
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | IVL CENPH KTN1 OTUB1 PLCL2 TTC21B ACTN4 XRCC4 CEP97 CCDC144A ARMC8 | 3.00e-04 | 1321 | 83 | 11 | 27173435 |
| Pubmed | The Tlx gene regulates the timing of neurogenesis in the cortex. | 3.05e-04 | 11 | 83 | 2 | 15385616 | |
| Pubmed | FBXW7 Facilitates Nonhomologous End-Joining via K63-Linked Polyubiquitylation of XRCC4. | 3.05e-04 | 11 | 83 | 2 | 26774286 | |
| Pubmed | 3.05e-04 | 11 | 83 | 2 | 32245946 | ||
| Pubmed | 3.49e-04 | 57 | 83 | 3 | 18022353 | ||
| Pubmed | NRSF regulates the fetal cardiac gene program and maintains normal cardiac structure and function. | 3.66e-04 | 12 | 83 | 2 | 14633990 | |
| Pubmed | 3.66e-04 | 12 | 83 | 2 | 8424456 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | 3.89e-04 | 934 | 83 | 9 | 33916271 | |
| Pubmed | 4.02e-04 | 144 | 83 | 4 | 35681168 | ||
| Pubmed | 4.07e-04 | 60 | 83 | 3 | 19075228 | ||
| Pubmed | Proteomics strategy to identify substrates of LNX, a PDZ domain-containing E3 ubiquitin ligase. | 4.07e-04 | 60 | 83 | 3 | 22889411 | |
| Pubmed | 4.07e-04 | 60 | 83 | 3 | 20682791 | ||
| Pubmed | Biological, clinical and population relevance of 95 loci for blood lipids. | 4.23e-04 | 146 | 83 | 4 | 20686565 | |
| Pubmed | 4.92e-04 | 64 | 83 | 3 | 36369321 | ||
| Pubmed | 4.93e-04 | 152 | 83 | 4 | 34299191 | ||
| Pubmed | Identification of protein arginine methyltransferase 2 as a coactivator for estrogen receptor alpha. | 5.03e-04 | 14 | 83 | 2 | 12039952 | |
| Pubmed | Multiplexed molecular interactions of nuclear receptors using fluorescent microspheres. | 5.03e-04 | 14 | 83 | 2 | 11500849 | |
| Pubmed | 5.14e-04 | 65 | 83 | 3 | 32521226 | ||
| Pubmed | 5.23e-04 | 421 | 83 | 6 | 36976175 | ||
| Interaction | POTEC interactions | 1.86e-07 | 13 | 83 | 4 | int:POTEC | |
| Interaction | POTED interactions | 2.69e-07 | 4 | 83 | 3 | int:POTED | |
| Interaction | POTEB3 interactions | 3.09e-07 | 35 | 83 | 5 | int:POTEB3 | |
| Interaction | NPM1 interactions | CUL1 MYH7 MYH10 AKAP5 ILF3 ACACA PSIP1 CENPC KTN1 OTUB1 PDCD11 MRPL19 XRCC4 TRIM24 AIM2 GOLGA3 NPM2 | 6.49e-06 | 1201 | 83 | 17 | int:NPM1 |
| Interaction | TRIM52 interactions | 1.84e-05 | 133 | 83 | 6 | int:TRIM52 | |
| Interaction | GOLGA4 interactions | 4.10e-05 | 226 | 83 | 7 | int:GOLGA4 | |
| GeneFamily | Ankyrin repeat domain containing|POTE ankyrin domain containing | 4.27e-08 | 13 | 52 | 4 | 685 | |
| GeneFamily | Ankyrin repeat domain containing | 6.42e-04 | 242 | 52 | 5 | 403 | |
| GeneFamily | Myosin heavy chains | 8.32e-04 | 15 | 52 | 2 | 1098 | |
| GeneFamily | Phospholipases|C2 domain containing phospholipases | 1.34e-03 | 19 | 52 | 2 | 832 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.86e-06 | 197 | 83 | 6 | fdb92985f7df0c280b87d3e43c2394e70786a2c7 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.66e-05 | 170 | 83 | 5 | e20568c8f3f17d94de78229617eb2f7e4c5af2bc | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.71e-05 | 171 | 83 | 5 | 4ede831aed364cb5271f49a8b09bb6d0452f9b35 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.96e-05 | 176 | 83 | 5 | d30241fb8119834d6e7b59efec3f92fc7a3d1247 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.96e-05 | 176 | 83 | 5 | cb8fd56a4f935cdda19d7ab43382cdda7c307667 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_G2M|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.07e-05 | 178 | 83 | 5 | c87945146b2734141f07b39d268e0d8086ee0364 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.13e-05 | 179 | 83 | 5 | ff678e2f33c914e3dd0f338ada25f506c3e3c980 | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.25e-05 | 181 | 83 | 5 | 719eb532453ab7cd7893726885bc75d74a10b21e | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | 2.69e-05 | 188 | 83 | 5 | 34e1b074a3995aa46ab194eb45115d76d1a5514d | |
| ToppCell | facs-Heart-RA-24m-Mesenchymal-ventricular_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.76e-05 | 189 | 83 | 5 | e758b264c0a47127e33e66c395cf5a3224c7305b | |
| ToppCell | facs-Heart-RA-24m-Mesenchymal-ventricular_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.76e-05 | 189 | 83 | 5 | b98f60875b1a12b2ec9dc91889298ae57f98602f | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 2.76e-05 | 189 | 83 | 5 | 0a82931b5f6c0a6427ca3edd5e2235ac49099d40 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.83e-05 | 190 | 83 | 5 | 2e88e366d377d74deb53a4ea870973ce5c6532e8 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 2.83e-05 | 190 | 83 | 5 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.83e-05 | 190 | 83 | 5 | 0028f886c789ba238c031eae5d96acaed4af8c25 | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|LV / Chamber and Cluster_Paper | 2.90e-05 | 191 | 83 | 5 | 25f3eb34f4e70761e81e84c8a5829f216108cbc6 | |
| ToppCell | droplet-Heart-4Chambers-21m-Mesenchymal-cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.90e-05 | 191 | 83 | 5 | c172c9e17b893b290e4aa8af5e5e4cd3e4818372 | |
| ToppCell | droplet-Heart-4Chambers-21m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.90e-05 | 191 | 83 | 5 | 715f5b449b8e075959c05a5b38389df319663164 | |
| ToppCell | LV-04._Ventricular_Cardiomyocyte_I|LV / Chamber and Cluster_Paper | 2.98e-05 | 192 | 83 | 5 | ad19e2c1d36a0566c9b12ced10db78f4781c8ea6 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.05e-05 | 193 | 83 | 5 | f25bdd10ef531b8d8441ea84573078b4b1b0f105 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.53e-05 | 199 | 83 | 5 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.53e-05 | 199 | 83 | 5 | 8b86c69aaf60feff53aa782559cfece7342a23de | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 3.62e-05 | 200 | 83 | 5 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_INF-Z|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.44e-04 | 142 | 83 | 4 | f720f13b339589fa924a42e89393e5db0b26300b | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.02e-04 | 155 | 83 | 4 | 441fcb6d05364fc6f4973f0b973f1a80b573ce1f | |
| ToppCell | Adult-Mesenchymal-vascular_smooth_muscle_cell-D122|Adult / Lineage, Cell type, age group and donor | 2.27e-04 | 160 | 83 | 4 | fd14dfeb7021a4b7299371854dc8fc1fd66c8dae | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.68e-04 | 167 | 83 | 4 | 83969c36ac44b96afc9aa09400a99fa2b487f7ff | |
| ToppCell | PND10-Immune-Immune_Myeloid-DC-cDC2-cDC2_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.74e-04 | 168 | 83 | 4 | 4c402a1613fcf0a6e4d9b9d5551812940e91ff32 | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.87e-04 | 170 | 83 | 4 | 3f15242a1d3e4e9871d9170b2ef05842fb609c29 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c5-CD16|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.00e-04 | 172 | 83 | 4 | 965a9f62b73a7e3531c343121a7c507b7e1bfe05 | |
| ToppCell | facs-Marrow-KLS-3m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.06e-04 | 173 | 83 | 4 | 8bffd512a4e561e23cc04478e2ca6fd5d3771fe4 | |
| ToppCell | facs-Marrow-KLS-3m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.06e-04 | 173 | 83 | 4 | 3e3c61468e703330788a10d850ef41a85680f86d | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-ASMC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.06e-04 | 173 | 83 | 4 | cb6389536195443633adb06e5f1b7483530773d1 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-B_(Myofibroblast)|390C / Donor, Lineage, Cell class and subclass (all cells) | 3.27e-04 | 176 | 83 | 4 | 852d3da0907fe87c0ef23d75a63ce07619cf0c54 | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.27e-04 | 176 | 83 | 4 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage_3|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 3.27e-04 | 176 | 83 | 4 | bfa1633e1b7a8a2f04d37fa07284fe9bc0199f46 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-B_(Myofibroblast)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 3.27e-04 | 176 | 83 | 4 | d2df1e435996c51213e88270af9f928e9e09a6f5 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-B_(Myofibroblast)|343B / Donor, Lineage, Cell class and subclass (all cells) | 3.34e-04 | 177 | 83 | 4 | e55d21d4d61a069b9bbe0e7595fbfb7cfbacfd87 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-B_(Myofibroblast)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 3.34e-04 | 177 | 83 | 4 | 43ba6f12c2fb32698a420bf799d46ac1b558f146 | |
| ToppCell | cellseq2-Mesenchymal-Fibroblastic-Fibroblastic_2-ASMC|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.41e-04 | 178 | 83 | 4 | 8ec2a25dda96c9cc9c2904b6cb18f75a293f4969 | |
| ToppCell | cellseq2-Mesenchymal-Fibroblastic-Fibroblastic_2|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.41e-04 | 178 | 83 | 4 | 6c91331196696e0cf239d105f458e3230659fa38 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3-Exc_L2-3_LINC00507_RPL9P17|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.48e-04 | 179 | 83 | 4 | 9ba8693fba2175bca9ff9735cc04e657abeb9084 | |
| ToppCell | Control-Fibroblasts-Airway_smooth_muscle|Control / group, cell type (main and fine annotations) | 3.56e-04 | 180 | 83 | 4 | d0de12749ef0f51f0931c6e7b9b99966bdbc3ec1 | |
| ToppCell | COVID-19-Heart-CM_3|Heart / Disease (COVID-19 only), tissue and cell type | 3.71e-04 | 182 | 83 | 4 | 287fcc3897ae08841f6f85ae6c9cef16f75b1dd1 | |
| ToppCell | COVID-19-Heart-CM_4|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.79e-04 | 183 | 83 | 4 | 2902b6e8aa9a6f62bc1a792c971ab7f651a8e676 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3-Exc_L2-3_LINC00507_RPL9P17|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.79e-04 | 183 | 83 | 4 | 1645d4a55cd8c22d6eb47fc5c6b1e576c454f111 | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 3.87e-04 | 184 | 83 | 4 | 9cbfb9f09476b4d09eb8f92c6f21e449dabcfa98 | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper | 3.87e-04 | 184 | 83 | 4 | ab7a1620c14a9d9b6be1b47c559931e345e9eef8 | |
| ToppCell | COVID-19-Heart-CM_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.87e-04 | 184 | 83 | 4 | e737f0f14c49b07bbb04a165083ac32210bc5690 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.87e-04 | 184 | 83 | 4 | 327ff3ac8d2fecdd5d242bdc34f0dfdb1c59a68b | |
| ToppCell | COVID-19-Heart-CM_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.95e-04 | 185 | 83 | 4 | 549eeb521c3985bff396ea0f202db21822efa51f | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.95e-04 | 185 | 83 | 4 | 9197f074e769d54031ec41abfc65fcc0c6552c7e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.95e-04 | 185 | 83 | 4 | ce7d62394b09c26ca65b8cdb280afec5e25bbb62 | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 3.95e-04 | 185 | 83 | 4 | 6baccb26f999145e51b91d94315bf8d4655bef31 | |
| ToppCell | LPS_only-Hematopoietic_Meg-Ery-Erythroid-Erythroid|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.03e-04 | 186 | 83 | 4 | e5014443e9d6e25943308483e20d48b776ae5373 | |
| ToppCell | facs-Heart-LA-24m-Mesenchymal-ventricular_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.03e-04 | 186 | 83 | 4 | 337f768cc43db2db96ba6495b076006b1a5b0331 | |
| ToppCell | facs-Heart-LA-24m-Mesenchymal-ventricular_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.03e-04 | 186 | 83 | 4 | e378c82ef6d6cb24751515aa499a01372b3e7ccf | |
| ToppCell | droplet-Marrow-nan-21m-Hematologic-erythroblast|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.03e-04 | 186 | 83 | 4 | 6e6998f5ccb1b2628048a21e8d3053e020569aba | |
| ToppCell | LPS_only-Hematopoietic_Meg-Ery-Erythroid|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.03e-04 | 186 | 83 | 4 | affc246a1091e44dc85a5e237c778a7541d5a2b4 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.03e-04 | 186 | 83 | 4 | 4780af76237d7af2abbe2d8d5530cdf53e3ed0b7 | |
| ToppCell | LPS_only-Hematopoietic_Meg-Ery|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.03e-04 | 186 | 83 | 4 | 40d1e15402fdfb3b5ae850a2070cd4b68fda3159 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.03e-04 | 186 | 83 | 4 | a95744b8649096bd7cfc3591a02841fa411085b3 | |
| ToppCell | COVID-19-Fibroblasts-Airway_smooth_muscle|COVID-19 / group, cell type (main and fine annotations) | 4.11e-04 | 187 | 83 | 4 | 464a0c3b92b778911b5f9cd73642e09e3472063a | |
| ToppCell | facs-Heart-LA/RA-3m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.19e-04 | 188 | 83 | 4 | 90dc0e15798d0b984518ad58c7e416e30aff687a | |
| ToppCell | Fibroblast-E_(Early_Fibroblastic_progenitor)|World / shred on cell class and cell subclass (v4) | 4.19e-04 | 188 | 83 | 4 | be3db9768364568f44e32ae6b3bf99e49b0978bb | |
| ToppCell | facs-Heart-LA/RA-3m-Mesenchymal-atrial_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.19e-04 | 188 | 83 | 4 | f63dfd076ced81013918363282ae25cbbd8948ae | |
| ToppCell | facs-Heart-LA/RA-3m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.19e-04 | 188 | 83 | 4 | 0554d542149cef654ff1e5e32dfbffd8990b52bd | |
| ToppCell | facs-Brain_Myeloid-Striatum-3m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.28e-04 | 189 | 83 | 4 | 6dd4ec5ce4beb856f0d2d1654e3c4676d1d63736 | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 4.28e-04 | 189 | 83 | 4 | 5e80c47f63980904c4c1ff02c201b67b456a0974 | |
| ToppCell | COVID-19-Heart-EC_(POSTN)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.28e-04 | 189 | 83 | 4 | 7346c1112e2e155dbd71b6dbc80e680fd262a691 | |
| ToppCell | facs-Heart-LA/RA-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.28e-04 | 189 | 83 | 4 | a08b2d0fa35ffa510050ecffdc68e1b79bbe1632 | |
| ToppCell | droplet-Marrow-BM_(NON-STC)-30m-Hematologic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.28e-04 | 189 | 83 | 4 | 16dfc37d8d390ed7f927bc844c47c9c5a89a0928 | |
| ToppCell | droplet-Marrow-BM_(NON-STC)-30m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.28e-04 | 189 | 83 | 4 | 3ade3fa9369e85304b20d7233b581f18ad5ecc89 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 4.28e-04 | 189 | 83 | 4 | 6b3e88751b95fc2173f2c3d5061ed632d0c5f01c | |
| ToppCell | facs-Brain_Myeloid-Striatum-3m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.28e-04 | 189 | 83 | 4 | 3ae479ec7e00c57127cbe51a398329b10ca9848c | |
| ToppCell | facs-Brain_Myeloid-Striatum-3m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.28e-04 | 189 | 83 | 4 | 875df61ee48baa5142ba4d2427bdec1c53e5a828 | |
| ToppCell | facs-Heart-LA/RA|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.28e-04 | 189 | 83 | 4 | efa913d9c16fc32166b484d92b6449e8a0c59e03 | |
| ToppCell | facs-Brain_Myeloid-Striatum-3m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.28e-04 | 189 | 83 | 4 | 97ef5215d841ff366a3e3682cd9bd04100cbfde0 | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 4.36e-04 | 190 | 83 | 4 | de5ef606a002f85c2e0e3a36c1f259d0b85a76ff | |
| ToppCell | COVID-19-Heart|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.36e-04 | 190 | 83 | 4 | 918ad5037881212008f9f69d5df5da91fd01422c | |
| ToppCell | Control-Endothelial-VE_Venous|Endothelial / Disease state, Lineage and Cell class | 4.36e-04 | 190 | 83 | 4 | 4e30155203b4a8c5e496fcbe9348b67b98ebc625 | |
| ToppCell | PCW_13-14|World / Celltypes from embryonic and fetal-stage human lung | 4.36e-04 | 190 | 83 | 4 | 62a3ec1ae0829602b0569cc051210551644f1d46 | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper | 4.36e-04 | 190 | 83 | 4 | fe8e78922c8ae928ef9a80bffd67868d5a87a091 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 4.45e-04 | 191 | 83 | 4 | 156b467187331ac6ca390d6ca861d9670bb7b956 | |
| ToppCell | droplet-Heart-nan-3m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.45e-04 | 191 | 83 | 4 | 97fb4232417a39801e87725755fd16a57c250209 | |
| ToppCell | droplet-Heart-nan-3m-Mesenchymal-cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.45e-04 | 191 | 83 | 4 | 64070a309d7e3f6001272409ab9ce206d0e7d73f | |
| ToppCell | droplet-Heart-nan-18m-Mesenchymal-cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.54e-04 | 192 | 83 | 4 | 0bf99e029a06151092db1e8a0dcb45f4e688e771 | |
| ToppCell | droplet-Heart-nan-18m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.54e-04 | 192 | 83 | 4 | d766221acfce30cbf2c60b3ae40f6744968b952c | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 4.63e-04 | 193 | 83 | 4 | dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 4.63e-04 | 193 | 83 | 4 | cd45118ced91b10baed3b1068d4673ec99824b86 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-NPC-like-NPC-like_neural-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.63e-04 | 193 | 83 | 4 | 088c8b1e968f5356502347eaabdc6b1b1d4befd0 | |
| ToppCell | E18.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.72e-04 | 194 | 83 | 4 | ae6d5cf4c825b29e677296df2c0985431c83b82e | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c05-ZNF683|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.72e-04 | 194 | 83 | 4 | 24837a27b0041fe8c348225fa8b09b127d743603 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-PMP-PMP_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.72e-04 | 194 | 83 | 4 | af4bbb2deb5a3913eb58990690fc3c62fbc3708c | |
| ToppCell | 390C-Epithelial_cells-Epithelial-I_(AT1)|390C / Donor, Lineage, Cell class and subclass (all cells) | 4.72e-04 | 194 | 83 | 4 | 88db9f9e80c20ff3474f1f6459dcbdc25aec0b6d | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.72e-04 | 194 | 83 | 4 | 5c3b2b05d1e4f146551fe4c920263d8e6ca34de3 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-I_(AT1)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 4.72e-04 | 194 | 83 | 4 | a71728202493d4858342ea2756ea281cd0d99a3a | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.72e-04 | 194 | 83 | 4 | ab9cad697f9209d2889bc02b43b502dfeb2ebfef | |
| ToppCell | COVID-19-Heart-CM_1|Heart / Disease (COVID-19 only), tissue and cell type | 4.81e-04 | 195 | 83 | 4 | f1ef50331eda8f1239dba6ea970df4eaccf032f1 | |
| ToppCell | COVID-19-Heart-CM_2|Heart / Disease (COVID-19 only), tissue and cell type | 4.81e-04 | 195 | 83 | 4 | 75fc81bddb246dca3b437fb60827b1d4fe416405 | |
| Disease | fornix volume measurement | 1.44e-04 | 7 | 78 | 2 | EFO_0803381 | |
| Disease | Hypertrophic Cardiomyopathy | 4.69e-04 | 57 | 78 | 3 | C0007194 | |
| Disease | restrictive cardiomyopathy (implicated_via_orthology) | 5.28e-04 | 13 | 78 | 2 | DOID:397 (implicated_via_orthology) | |
| Disease | eating disorder, bipolar disorder | 6.15e-04 | 14 | 78 | 2 | EFO_0005203, MONDO_0004985 | |
| Disease | response to methotrexate, neurotoxicity | 1.15e-03 | 19 | 78 | 2 | EFO_0011057, GO_0031427 | |
| Disease | beverage consumption measurement | 1.40e-03 | 83 | 78 | 3 | EFO_0010088 | |
| Disease | Hyalinosis, Segmental Glomerular | 2.49e-03 | 28 | 78 | 2 | C0086432 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KRVQMEQPDAVPAQK | 866 | Q7Z4L5 | |
| PIQMKPADSEKNNAV | 91 | Q92879 | |
| VKPEQKQMVAQQESI | 131 | O14862 | |
| PDEMNNSPNFEEKKK | 851 | Q14687 | |
| TEEQMAQQPPKGQAQ | 136 | Q6IC98 | |
| PPSQEVNDAIKQMKK | 1546 | O95477 | |
| PQKTIQEMQQKLEDF | 321 | O43707 | |
| NDNQETAAMKPENLK | 266 | A2A2Z9 | |
| AKMQLDNPSKVQQAE | 816 | Q13085 | |
| DKAVKPAMNQNEVQE | 221 | Q5SZJ8 | |
| DVPNSQPEMVEAVKK | 46 | P08476 | |
| NEAMQPTANEVEQPK | 516 | Q6ZMN7 | |
| VKEDQVMQQNPPKFD | 71 | P12883 | |
| SQPEKMSQEPEINKD | 396 | A5A3E0 | |
| KPQDPMEQNVAELLQ | 486 | Q9HCI5 | |
| KVMEQQSNLQPEAKE | 2146 | Q8IWI9 | |
| LPPEQQMLQKQEKEA | 201 | Q8N5G2 | |
| PMKENQPNEVPEDNL | 536 | A0A1B0GTH6 | |
| KDPPKKNAMNELQDE | 551 | O60447 | |
| NQGAMNPLEKEIQEP | 856 | P48681 | |
| KMDQTNKAGEIPQPV | 716 | Q8NEV8 | |
| VSEQPNKDVVEQMEK | 721 | Q86UP2 | |
| QDETQQLQPDMSKLP | 51 | Q96RT7 | |
| PQNVMAQQKVTKEEA | 1311 | Q6ZVL6 | |
| LSKQPVGNQEMENLK | 1276 | Q08378 | |
| KEQVDPLQMKLQQVN | 5281 | Q9UPN3 | |
| GQMLQKEPEEEQQKQ | 551 | Q8IV76 | |
| KVSENSQPEKMSQEP | 391 | A0JP26 | |
| SQPEKMSQEPEINKD | 396 | A0JP26 | |
| NNQSDLEKEMQKMNP | 61 | P49642 | |
| MAAEEPQQQKQEPLG | 1 | Q96FW1 | |
| PDPQKVLQGVIDMKN | 31 | Q8IUR7 | |
| NVNKENKEKQPTMPI | 831 | Q9Y4C1 | |
| EKTPEQIMQEKQIEA | 66 | Q9H3R5 | |
| TKPQQLQEEMKELQQ | 936 | Q5THR3 | |
| KNEDNIMTAQNVPLK | 641 | Q03188 | |
| KQSDIKKPENTQPEN | 511 | Q8IW35 | |
| RVNINVPMKTEQKQE | 681 | Q13616 | |
| QEDPPLMVKKNSVVQ | 766 | Q8ND61 | |
| QKKEEKAEPPQAMNA | 391 | Q12906 | |
| ENKQPQKTSQEPEMA | 241 | Q3MJ40 | |
| KQQKPLEGEMQPAIN | 96 | P24588 | |
| APQNIEEQDIVMKKQ | 5821 | Q8NDH2 | |
| DPQPFAVDKQQMQKL | 6206 | Q8NDH2 | |
| ENKQPQKTSQEPEMA | 241 | A2RUR9 | |
| LQEPEKKSQMPNTTE | 206 | O95661 | |
| QLVENIDKKMTDPNQ | 666 | Q9BXA9 | |
| PMPEVQEKFQEQKAK | 4411 | Q92736 | |
| PPANQEDKKMQPVTI | 66 | Q86SE8 | |
| SPPQEMSQEDLKEKN | 91 | Q56UN5 | |
| PIPGQQDKDNFQETM | 316 | P35580 | |
| QNQPKADKDESTMIN | 1431 | Q5THK1 | |
| ANINTQDPKIQKEIM | 606 | Q2NL67 | |
| KVSENSQPEKMSQEP | 391 | B2RU33 | |
| SQPEKMSQEPEINKD | 396 | B2RU33 | |
| DQKMQQPEKVSVQID | 631 | Q9UPX6 | |
| KVSENSQPEKMSQEP | 391 | Q86YR6 | |
| SQPEKMSQEPEINKD | 396 | Q86YR6 | |
| PANQKKMEETIPDQQ | 376 | A2RUB1 | |
| PMQTDEQTNKEQFVP | 526 | O60502 | |
| EKKEQMDPCNTNPTP | 776 | Q15788 | |
| MGKENMEQPNNVPVK | 596 | Q9UPR0 | |
| SQPEKMSQEPEINKD | 396 | P0CG38 | |
| RQQKGVTQPKEEMAQ | 121 | Q5SSQ6 | |
| LDQQEKQPELPEQQM | 296 | P07476 | |
| VPPITVNAKMNKDVN | 591 | Q14CN2 | |
| QMETEQQNKDEGKKP | 321 | O75475 | |
| DVNMKPVVQEPNQKV | 201 | P49406 | |
| EMPSKEKQQPQKPQA | 1451 | Q14690 | |
| PEQKKVAQDMTQPLS | 391 | Q15111 | |
| LQPEMPQKQAEKVVI | 96 | Q9NUW8 | |
| MNQAKVPVDGNKEEP | 126 | Q9NRF8 | |
| EDKESQPQMPKQNPV | 426 | O15164 | |
| SDPMPVTQKEQENKS | 81 | Q96T68 | |
| KIDNQSQPLGNKVEM | 286 | P28289 | |
| NKKNDEMQEVPNRVL | 21 | Q5MJ09 | |
| MPTTQQSPQDEQEKL | 1 | Q96QK1 | |
| GTEPKMAPQENQLQE | 281 | Q13426 | |
| IDQKMPDIEPNSENN | 956 | Q8IZM8 | |
| QPVKQENEKPLPENM | 76 | Q4J6C6 | |
| MDTQKDVQPPKQQPM | 1 | P53803 | |
| LQLQKEVDKEQMVPN | 451 | Q8IYW5 | |
| KPQLSMPQKSDNGEV | 816 | Q5JVG2 | |
| MEDPNPEENMKQQDS | 1 | Q9H609 | |
| VVIEIKNMPNKQPES | 491 | Q9Y6M5 | |
| DQQEHVVPKSQPKTM | 236 | P35125 | |
| NTPKQLEMEKNAEPT | 1211 | Q9NR99 | |
| QNPPKVIMELFDNDQ | 1206 | Q9NZM1 | |
| NKEEMNRIQKPNEVS | 371 | Q86TC9 |